Abstract
Summary
In a human subject, hypoprothrombinemia and the secondary hemorrhagic phenomena induced by multiple large doses of dicoumarol appeared to be corrected by the intravenous administration of a single massive dose of vitamin K1 oxide. The period of time elapsing between the institution of treatment with vitamin K1 oxide and the cessation of hemorrhagic phenomena is too long to make this method entirely satisfactory.
Get full access to this article
View all access options for this article.